FDA Approved: DIFLUPREDNATE — Original Application (Upsher-Smith Laboratories, LLC)

View source ↗

Summary

FDA approved the original application for difluprednate from Upsher-Smith Laboratories, enabling a generic ophthalmic corticosteroid for postoperative ocular in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation of the Eye
• Postoperative Inflammation

Drugs mentioned

• DIFLUPREDNATE (difluprednate)

Snippet

ORIG AP for DIFLUPREDNATE (DIFLUPREDNATE)